Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Linsitinib (OSI-906)
Cat No.
CEI-0045
Description
Linsitinib (OSI-906) can inhibit IGF-1R and IR with IC50 of 35 nM and 75 nM.
CAS No.
867160-71-2
Molecular Weight
421.49
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
IGF-1R, IR
Molecular Formula
C26H23N5O
Chemical Name
(1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol
Solubility
DMSO 84 mg/mL Water
In vitro
Linsitinib (OSI-906) is a dual inhibitor of the IGF-1 receptor and insulin receptor. OSI-906 shows inhibition to hepatocellular carcinoma (HCC).
In vivo
A subset of HCC tumor cell lines was sensitive to OSI-906, where inhibition of the AKT pathway, but not the extracellular signal-regulated kinase (ERK) pathway, was associated with sensitivity.
Download
Download Datasheet